淳中科技(603516.SH):股東及部分董監高擬合計減持不超1.7997%的股份
格隆匯12月16日丨淳中科技(603516.SH)公佈,天津斯豪,計劃自公吿披露之日起3個交易日後的六個月內以大宗交易方式,或者自公吿披露之日起15個交易日後的六個月內以集中競價交易方式,通過上海證券交易所交易系統合計減持不超過333.2814萬股(包含董事、監事及高管人員通過天津斯豪間接減持股數:董事長何仕達23.52萬股、董事王志濤9.9444萬股、監事胡沉6.405萬股、監事阮航2.94萬股),約佔公司當前總股本的1.7997%。
天津斯豪保證任意連續90個自然日內通過集中競價交易方式或者大宗交易方式減持股份分別不超過公司總股本的1%和2%,減持價格視市場情況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.